HIMS HERS HEALTH INC

NYSE: HIMS (Hims & Hers Health, Inc.)

最近更新时间: 15 Jul, 1:15PM

50.89

-1.14 (-2.19%)

前收盘价格 52.03
收盘价格 53.00
成交量 15,544,789
平均成交量 (3个月) 47,019,461
市值 11,390,810,112
市盈率 (P/E TTM) 74.84
预期市盈率 (P/E Forward) 96.15
价格/销量 (P/S) 6.25
股市价格/股市净资产 (P/B) 20.51
52周波幅
13.47 (-73%) — 72.98 (43%)
利润日期 4 Aug 2025
营业毛利率 9.21%
营业利益率 (TTM) 10.12%
稀释每股收益 (EPS TTM) 0.680
季度收入增长率 (YOY) 110.70%
季度盈利增长率 (YOY) 344.70%
总债务/股东权益 (D/E MRQ) 11.54%
流动比率 (MRQ) 1.59
营业现金流 (OCF TTM) 334.34 M
杠杆自由现金流 (LFCF TTM) 213.45 M
资产报酬率 (ROA TTM) 10.76%
股东权益报酬率 (ROE TTM) 36.79%

市场趋势

短期 中期
行业 Household & Personal Products (US) 看跌 看跌
Household & Personal Products (全球的) 看跌 看跌
股票 Hims & Hers Health, Inc. 看涨 看涨

AIStockmoo 评分

-0.2
分析师共识 -1.5
内部交易活动 -3.5
价格波动 -0.5
技术平均移动指标 5.0
技术振荡指标 -0.5
平均 -0.20

相关股票

股票 市值 DY P/E(TTM) P/B
HIMS 11 B - 74.84 20.51
ELF 7 B - 61.27 8.94
PG 360 B 1.31% 23.58 7.02
UL 150 B 2.33% 23.39 7.23
CL 75 B 1.08% 26.28 97.50
KMB 45 B 3.64% 18.63 35.54

Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.

部门 Consumer Defensive
行业 Household & Personal Products
投资方式 Small Growth
内部持股比例 11.13%
机构持股比例 82.47%

所有权

姓名 日期 持有股份
Yong Rong (Hk) Asset Management Ltd 31 Mar 2025 2,400,000
52周波幅
13.47 (-73%) — 72.98 (43%)
目标价格波幅
40.00 (-21%) — 65.00 (27%)
65.00 (Needham, 27.73%) 购买
48.00 (-5.68%)
40.00 (Morgan Stanley, -21.40%) 保留
平均值 51.00 (0.22%)
总计 1 购买, 2 保留
平均价格@调整类型 53.72
公司 日期 目标价格 调整类型 价格@调整类型
Truist Securities 17 Jul 2025 48.00 (-5.68%) 保留 49.99
Morgan Stanley 11 Jun 2025 40.00 (-21.40%) 保留 57.56
Needham 04 Jun 2025 65.00 (27.73%) 购买 53.61
名称 平均购买 ($) 平均卖出 ($) 总净额 总净值 ($)
BOUGHTON SOLEIL - 58.68 -2,572 -150,925
CHI MICHAEL - 64.37 -26,600 -1,759,481
累积净数量 -29,172
累积净值 ($) -1,910,405
累积平均购买 ($) -
累积平均卖出 ($) 62.47
名称 持有人 日期 类型 数量 价格 价值 ($)
CHI MICHAEL 职员 01 Aug 2025 自动卖出 (-) 250 62.55 15,638
CHI MICHAEL 职员 01 Aug 2025 执行期权 250 - -
CHI MICHAEL 职员 31 Jul 2025 自动卖出 (-) 26,350 66.18 1,743,843
CHI MICHAEL 职员 31 Jul 2025 执行期权 26,350 - -
BOUGHTON SOLEIL 职员 28 Jul 2025 自动卖出 (-) 2,572 58.68 150,925
日期 类型 细节
07 Aug 2025 公告 Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
05 Aug 2025 公告 Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
04 Aug 2025 公告 Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
04 Aug 2025 公告 Hims & Hers Health, Inc. Reports Second Quarter 2025 Financial Results
31 Jul 2025 公告 Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
29 Jul 2025 公告 Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care
29 Jul 2025 公告 Hims & Hers Health (HIMS) Investors: August 25, 2025 Filing Deadline in Securities Class Action - Contact Lieff Cabraser
14 Jul 2025 公告 Hims & Hers to Announce Second Quarter 2025 Financial Results on August 4, 2025
09 Jul 2025 公告 Hims & Hers Announces Planned 2026 Expansion to Canada, Following ZAVA Acquisition Completion
09 Jul 2025 CNBC Hims & Hers to offer generic semaglutide in Canada as Novo Nordisk patent lapses
08 Jul 2025 公告 INVESTOR ACTION NOTICE: Moore Law PLLC Encourages Investors in Hims & Hers Health Inc. to Contact Law Firm
28 Jun 2025 公告 HIMS INVESTOR NOTICE: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
23 Jun 2025 CNBC Novo Nordisk ends deal with Hims & Hers over sales of Wegovy copycats; HIMS drops 34%
03 Jun 2025 公告 Hims & Hers Announces Plans to Acquire ZAVA, Accelerating Major European Growth Across the UK, Germany, France, and Ireland
03 Jun 2025 CNBC Hims & Hers to acquire European telehealth platform in global expansion
22 May 2025 公告 Hims & Hers Introduces 6-Month Wegovy® New Customer Offer
显示更多

支撑、阻力和趋势线水平是由人工智能(AI)模型生成的,请谨慎解读。

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2025 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票